Evidence map›Paper›PMID 41815960›Full record

ArticleFrontiers in public health2026

Attractiveness and determinants of different tobacco products among Chinese smokers and non-smokers: a web-based cross-sectional study.

Ting Fei, Dawei Yan, Xiaomin Liu, Yuyan Li, Yihan Gao, Xiaonan Li, Guangchao Liu, Bingxue Wu, Yishi Jiang, Yan Zhang and 2 more

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ting FeiShanghai New Tobacco Product Research Institute Co., Ltd., Shanghai, China.
Dawei YanShanghai New Tobacco Product Research Institute Co., Ltd., Shanghai, China.
Xiaomin LiuShanghai New Tobacco Product Research Institute Co., Ltd., Shanghai, China.
Yuyan LiNHC Key Lab of Reproduction Regulation, Shanghai Engineering Research Center of Reproductive Health Drug and Devices, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China.
Yihan GaoShanghai New Tobacco Product Research Institute Co., Ltd., Shanghai, China.
Xiaonan LiShanghai New Tobacco Product Research Institute Co., Ltd., Shanghai, China.
Guangchao LiuShanghai New Tobacco Product Research Institute Co., Ltd., Shanghai, China.
Bingxue WuNHC Key Lab of Reproduction Regulation, Shanghai Engineering Research Center of Reproductive Health Drug and Devices, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China.
Yishi JiangNHC Key Lab of Reproduction Regulation, Shanghai Engineering Research Center of Reproductive Health Drug and Devices, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China.
Yan ZhangNHC Key Lab of Reproduction Regulation, Shanghai Engineering Research Center of Reproductive Health Drug and Devices, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China.
Yan CheNHC Key Lab of Reproduction Regulation, Shanghai Engineering Research Center of Reproductive Health Drug and Devices, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China.
Saijing ZhengShanghai New Tobacco Product Research Institute Co., Ltd., Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Tobacco use remains highly prevalent in China, with the emergence of a growing range of tobacco and nicotine products that vary in design and social presentation, raising questions about how these product characteristics are perceived by consumers. This study assessed the attractiveness of five tobacco products among the general Chinese public, including both non-smokers and smokers, and explored the factors influencing their perceived appeal. Methods: Using a self-designed attractiveness scale, an online survey was administered via smartphone to adults aged 18 years or older across six geographically representative cities in China (Beijing, Shanghai, Guangzhou, Shenzhen, Chengdu, and Zhengzhou). The survey assessed the attractiveness of five tobacco products, including combustible cigarette (CC), e-cigarette (EC), heated tobacco product (HTP), oral nicotine product (ONP) and tobacco-free oral nicotine pouch (TFONP). Attractiveness ratings for different tobacco products were calculated, and mixed linear models were employed to explore associated influencing factors. Results: A total of 15,601 valid questionnaires were collected, including 9,700 non-smokers and 5,901 smokers. CC had the highest familiarity score (3.97 ± 1.04) and were perceived as having the highest health risks (4.38 ± 0.76) and the highest addictiveness (4.22 ± 0.87). All alternative tobacco products received significantly lower ratings on these measures compared with CC (all Conclusion: This study identified distinct patterns of perceived appeal across five tobacco/nicotine product types among Chinese adults. E-cigarettes received the highest appeal ratings among non-smokers, whereas combustible cigarettes remained the most appealing among CC users. Prior product use history showed the strongest association with appeal. Perceived health risks were inversely associated with appeal and appeared to partly account for the smoking-appeal association, as the association between smoking status and attractiveness ratings changed after adjustment for perceived health risks. In contrast, greater familiarity and higher perceived social support were positively associated with appeal.

Indexed as

Non-SmokersSmokersTobacco ProductsAdolescentAdultChinaCross-Sectional StudiesEast Asian PeopleFemaleHumansInternetMaleMiddle AgedSurveys and QuestionnairesYoung Adultappeal scoreChinacombustible cigarettesnon-smokers and smokersnovel tobacco products

Identifiers

PMID41815960
PMCPMC12971477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.